1 Study Coverage 1.1 Recombinant Antibodies (rAbs) Product Introduction 1.2 Market by Type 1.2.1 Global Recombinant Antibodies (rAbs) Market Size Growth Rate by Type 1.2.2 Rabbit 1.2.3 Mouse 1.2.4 Goat 1.2.5 Others 1.3 Market by Application 1.3.1 Global Recombinant Antibodies (rAbs) Market Size Growth Rate by Application 1.3.2 Hospitals & Diagnostic Laboratories 1.3.3 Pharmaceutical & Biotechnology 1.3.4 Research Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Recombinant Antibodies (rAbs) Market Size, Estimates and Forecasts 2.1.1 Global Recombinant Antibodies (rAbs) Revenue 2016-2027 2.1.2 Global Recombinant Antibodies (rAbs) Sales 2016-2027 2.2 Global Recombinant Antibodies (rAbs), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Recombinant Antibodies (rAbs) Historical Market Size by Region (2016-2021) 2.3.1 Global Recombinant Antibodies (rAbs) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Recombinant Antibodies (rAbs) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Recombinant Antibodies (rAbs) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Recombinant Antibodies (rAbs) Sales Forecast by Region (2022-2027) 2.4.2 Global Recombinant Antibodies (rAbs) Revenue Forecast by Region (2022-2027) 3 Global Recombinant Antibodies (rAbs) Competitor Landscape by Players 3.1 Global Top Recombinant Antibodies (rAbs) Manufacturers by Sales 3.1.1 Global Recombinant Antibodies (rAbs) Sales by Manufacturer (2016-2021) 3.1.2 Global Recombinant Antibodies (rAbs) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Recombinant Antibodies (rAbs) Manufacturers by Revenue 3.2.1 Key Recombinant Antibodies (rAbs) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Recombinant Antibodies (rAbs) Revenue by Manufacturers (2016-2021) 3.2.3 Global Recombinant Antibodies (rAbs) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Recombinant Antibodies (rAbs) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Recombinant Antibodies (rAbs) Revenue in 2020 3.2.6 Global Recombinant Antibodies (rAbs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Recombinant Antibodies (rAbs) Price by Manufacturers 3.4 Global Recombinant Antibodies (rAbs) Manufacturing Base Distribution, Product Types 3.4.1 Recombinant Antibodies (rAbs) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Recombinant Antibodies (rAbs) Product Type 3.4.3 Date of International Manufacturers Enter into Recombinant Antibodies (rAbs) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Recombinant Antibodies (rAbs) Market Size by Type (2016-2021) 4.1.1 Global Recombinant Antibodies (rAbs) Sales by Type (2016-2021) 4.1.2 Global Recombinant Antibodies (rAbs) Revenue by Type (2016-2021) 4.1.3 Recombinant Antibodies (rAbs) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Recombinant Antibodies (rAbs) Market Size Forecast by Type (2022-2027) 4.2.1 Global Recombinant Antibodies (rAbs) Sales Forecast by Type (2022-2027) 4.2.2 Global Recombinant Antibodies (rAbs) Revenue Forecast by Type (2022-2027) 4.2.3 Recombinant Antibodies (rAbs) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Recombinant Antibodies (rAbs) Market Size by Application (2016-2021) 5.1.1 Global Recombinant Antibodies (rAbs) Sales by Application (2016-2021) 5.1.2 Global Recombinant Antibodies (rAbs) Revenue by Application (2016-2021) 5.1.3 Recombinant Antibodies (rAbs) Price by Application (2016-2021) 5.2 Recombinant Antibodies (rAbs) Market Size Forecast by Application (2022-2027) 5.2.1 Global Recombinant Antibodies (rAbs) Sales Forecast by Application (2022-2027) 5.2.2 Global Recombinant Antibodies (rAbs) Revenue Forecast by Application (2022-2027) 5.2.3 Global Recombinant Antibodies (rAbs) Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 6.1.1 United States Recombinant Antibodies (rAbs) Sales YoY Growth 2016-2027 6.1.2 United States Recombinant Antibodies (rAbs) Revenue YoY Growth 2016-2027 6.1.3 United States Recombinant Antibodies (rAbs) Market Share in Global Market 2016-2027 6.2 United States Recombinant Antibodies (rAbs) Market Size by Players (International and Local Players) 6.2.1 United States Top Recombinant Antibodies (rAbs) Players by Sales (2016-2021) 6.2.2 United States Top Recombinant Antibodies (rAbs) Players by Revenue (2016-2021) 6.3 United States Recombinant Antibodies (rAbs) Historic Market Review by Type (2016-2021) 6.3.1 United States Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021) 6.3.2 United States Recombinant Antibodies (rAbs) Revenue Market Share by Type (2016-2021) 6.3.3 United States Recombinant Antibodies (rAbs) Price by Type (2016-2021) 6.4 United States Recombinant Antibodies (rAbs) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Recombinant Antibodies (rAbs) Sales Forecast by Type (2022-2027) 6.4.2 United States Recombinant Antibodies (rAbs) Revenue Forecast by Type (2022-2027) 6.4.3 United States Recombinant Antibodies (rAbs) Price Forecast by Type (2022-2027) 6.5 United States Recombinant Antibodies (rAbs) Historic Market Review by Application (2016-2021) 6.5.1 United States Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021) 6.5.2 United States Recombinant Antibodies (rAbs) Revenue Market Share by Application (2016-2021) 6.5.3 United States Recombinant Antibodies (rAbs) Price by Application (2016-2021) 6.6 United States Recombinant Antibodies (rAbs) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Recombinant Antibodies (rAbs) Sales Forecast by Application (2022-2027) 6.6.2 United States Recombinant Antibodies (rAbs) Revenue Forecast by Application (2022-2027) 6.6.3 United States Recombinant Antibodies (rAbs) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 7.2 North America Recombinant Antibodies (rAbs) Market Facts & Figures by Country 7.2.1 North America Recombinant Antibodies (rAbs) Sales by Country (2016-2021) 7.2.2 North America Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Recombinant Antibodies (rAbs) Market Facts & Figures by Region 8.2.1 Asia Pacific Recombinant Antibodies (rAbs) Sales by Region (2016-2021) 8.2.2 Asia Pacific Recombinant Antibodies (rAbs) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 9.2 Europe Recombinant Antibodies (rAbs) Market Facts & Figures by Country 9.2.1 Europe Recombinant Antibodies (rAbs) Sales by Country (2016-2021) 9.2.2 Europe Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 10.2 Latin America Recombinant Antibodies (rAbs) Market Facts & Figures by Country 10.2.1 Latin America Recombinant Antibodies (rAbs) Sales by Country (2016-2021) 10.2.2 Latin America Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Recombinant Antibodies (rAbs) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Recombinant Antibodies (rAbs) Market Facts & Figures by Country 11.2.1 Middle East and Africa Recombinant Antibodies (rAbs) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Abcam 12.1.1 Abcam Corporation Information 12.1.2 Abcam Description and Business Overview 12.1.3 Abcam Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abcam Recombinant Antibodies (rAbs) Products Offered 12.1.5 Abcam Recent Development 12.2 Abeomics 12.2.1 Abeomics Corporation Information 12.2.2 Abeomics Description and Business Overview 12.2.3 Abeomics Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abeomics Recombinant Antibodies (rAbs) Products Offered 12.2.5 Abeomics Recent Development 12.3 Abnova Corporation 12.3.1 Abnova Corporation Corporation Information 12.3.2 Abnova Corporation Description and Business Overview 12.3.3 Abnova Corporation Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Abnova Corporation Recombinant Antibodies (rAbs) Products Offered 12.3.5 Abnova Corporation Recent Development 12.4 Absolute Antibody 12.4.1 Absolute Antibody Corporation Information 12.4.2 Absolute Antibody Description and Business Overview 12.4.3 Absolute Antibody Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Absolute Antibody Recombinant Antibodies (rAbs) Products Offered 12.4.5 Absolute Antibody Recent Development 12.5 Activity Signaling 12.5.1 Activity Signaling Corporation Information 12.5.2 Activity Signaling Description and Business Overview 12.5.3 Activity Signaling Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Activity Signaling Recombinant Antibodies (rAbs) Products Offered 12.5.5 Activity Signaling Recent Development 12.6 AIVD Biotech 12.6.1 AIVD Biotech Corporation Information 12.6.2 AIVD Biotech Description and Business Overview 12.6.3 AIVD Biotech Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 AIVD Biotech Recombinant Antibodies (rAbs) Products Offered 12.6.5 AIVD Biotech Recent Development 12.7 Bio X Cell 12.7.1 Bio X Cell Corporation Information 12.7.2 Bio X Cell Description and Business Overview 12.7.3 Bio X Cell Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Bio X Cell Recombinant Antibodies (rAbs) Products Offered 12.7.5 Bio X Cell Recent Development 12.8 BioLegend 12.8.1 BioLegend Corporation Information 12.8.2 BioLegend Description and Business Overview 12.8.3 BioLegend Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 BioLegend Recombinant Antibodies (rAbs) Products Offered 12.8.5 BioLegend Recent Development 12.9 Bio-Rad 12.9.1 Bio-Rad Corporation Information 12.9.2 Bio-Rad Description and Business Overview 12.9.3 Bio-Rad Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Bio-Rad Recombinant Antibodies (rAbs) Products Offered 12.9.5 Bio-Rad Recent Development 12.10 Bon Opus Biosciences 12.10.1 Bon Opus Biosciences Corporation Information 12.10.2 Bon Opus Biosciences Description and Business Overview 12.10.3 Bon Opus Biosciences Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Bon Opus Biosciences Recombinant Antibodies (rAbs) Products Offered 12.10.5 Bon Opus Biosciences Recent Development 12.11 Abcam 12.11.1 Abcam Corporation Information 12.11.2 Abcam Description and Business Overview 12.11.3 Abcam Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abcam Recombinant Antibodies (rAbs) Products Offered 12.11.5 Abcam Recent Development 12.12 Creative Diagnostics 12.12.1 Creative Diagnostics Corporation Information 12.12.2 Creative Diagnostics Description and Business Overview 12.12.3 Creative Diagnostics Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Creative Diagnostics Products Offered 12.12.5 Creative Diagnostics Recent Development 12.13 Enzo Life Sciences, Inc. 12.13.1 Enzo Life Sciences, Inc. Corporation Information 12.13.2 Enzo Life Sciences, Inc. Description and Business Overview 12.13.3 Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Enzo Life Sciences, Inc. Products Offered 12.13.5 Enzo Life Sciences, Inc. Recent Development 12.14 GRP GmbH 12.14.1 GRP GmbH Corporation Information 12.14.2 GRP GmbH Description and Business Overview 12.14.3 GRP GmbH Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.14.4 GRP GmbH Products Offered 12.14.5 GRP GmbH Recent Development 12.15 HUABIO 12.15.1 HUABIO Corporation Information 12.15.2 HUABIO Description and Business Overview 12.15.3 HUABIO Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.15.4 HUABIO Products Offered 12.15.5 HUABIO Recent Development 12.16 Miltenyi Biotec 12.16.1 Miltenyi Biotec Corporation Information 12.16.2 Miltenyi Biotec Description and Business Overview 12.16.3 Miltenyi Biotec Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Miltenyi Biotec Products Offered 12.16.5 Miltenyi Biotec Recent Development 12.17 NSJ Bioreagents 12.17.1 NSJ Bioreagents Corporation Information 12.17.2 NSJ Bioreagents Description and Business Overview 12.17.3 NSJ Bioreagents Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.17.4 NSJ Bioreagents Products Offered 12.17.5 NSJ Bioreagents Recent Development 12.18 PROGEN 12.18.1 PROGEN Corporation Information 12.18.2 PROGEN Description and Business Overview 12.18.3 PROGEN Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.18.4 PROGEN Products Offered 12.18.5 PROGEN Recent Development 12.19 RevMab Biosciences USA, Inc. 12.19.1 RevMab Biosciences USA, Inc. Corporation Information 12.19.2 RevMab Biosciences USA, Inc. Description and Business Overview 12.19.3 RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.19.4 RevMab Biosciences USA, Inc. Products Offered 12.19.5 RevMab Biosciences USA, Inc. Recent Development 12.20 Signalway Antibody LLC 12.20.1 Signalway Antibody LLC Corporation Information 12.20.2 Signalway Antibody LLC Description and Business Overview 12.20.3 Signalway Antibody LLC Recombinant Antibodies (rAbs) Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Signalway Antibody LLC Products Offered 12.20.5 Signalway Antibody LLC Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Recombinant Antibodies (rAbs) Industry Trends 13.2 Recombinant Antibodies (rAbs) Market Drivers 13.3 Recombinant Antibodies (rAbs) Market Challenges 13.4 Recombinant Antibodies (rAbs) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Recombinant Antibodies (rAbs) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Recombinant Antibodies (rAbs) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Rabbit Table 3. Major Manufacturers of Mouse Table 4. Major Manufacturers of Goat Table 5. Major Manufacturers of Others Table 6. Global Recombinant Antibodies (rAbs) Market Size Growth Rate by Application (2021-2027) & (L) Table 7. Global Recombinant Antibodies (rAbs) Market Size by Region (L) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Recombinant Antibodies (rAbs) Sales by Regions (2016-2021) & (L) Table 9. Global Recombinant Antibodies (rAbs) Sales Market Share by Regions (2016-2021) Table 10. Global Recombinant Antibodies (rAbs) Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Recombinant Antibodies (rAbs) Sales Forecast by Region (2022-2027) & (L) Table 12. Global Recombinant Antibodies (rAbs) Sales Market Share Forecast by Region (2022-2027) Table 13. Global Recombinant Antibodies (rAbs) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Recombinant Antibodies (rAbs) Sales by Manufacturers (2016-2021) (L) Table 16. Global Recombinant Antibodies (rAbs) Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Recombinant Antibodies (rAbs) Manufacturers by Revenue (US$ Million) in 2020 Table 18. Recombinant Antibodies (rAbs) Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Recombinant Antibodies (rAbs) Revenue Share by Manufacturers (2016-2021) Table 20. Global Recombinant Antibodies (rAbs) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Recombinant Antibodies (rAbs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibodies (rAbs) as of 2020) Table 22. Key Manufacturers Recombinant Antibodies (rAbs) Price (2016-2021) (US$/ul) Table 23. Recombinant Antibodies (rAbs) Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Recombinant Antibodies (rAbs) Product Type Table 25. Date of International Manufacturers Enter into Recombinant Antibodies (rAbs) Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Recombinant Antibodies (rAbs) Sales by Type (2016-2021) (L) Table 28. Global Recombinant Antibodies (rAbs) Sales Share by Type (2016-2021) Table 29. Global Recombinant Antibodies (rAbs) Revenue by Type (2016-2021) (US$ Million) Table 30. Global Recombinant Antibodies (rAbs) Revenue Share by Type (2016-2021) Table 31. Recombinant Antibodies (rAbs) Average Selling Price (ASP) by Type (2016-2021) & (US$/ul) Table 32. Global Recombinant Antibodies (rAbs) Sales Forecast by Type (2022-2027) & (L) Table 33. Global Recombinant Antibodies (rAbs) Sales Market Share Forecast by Type (2022-2027) Table 34. Global Recombinant Antibodies (rAbs) Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Recombinant Antibodies (rAbs) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/ul) Table 37. Global Recombinant Antibodies (rAbs) Sales by Application (2016-2021) (L) Table 38. Global Recombinant Antibodies (rAbs) Sales Share by Application (2016-2021) Table 39. Global Recombinant Antibodies (rAbs) Revenue by Application (2016-2021) (US$ Million) Table 40. Global Recombinant Antibodies (rAbs) Revenue Share by Application (2016-2021) Table 41. Recombinant Antibodies (rAbs) Average Selling Price (ASP) by Application (2016-2021) & (US$/ul) Table 42. Global Recombinant Antibodies (rAbs) Sales Forecast by Application (2022-2027) & (L) Table 43. Global Recombinant Antibodies (rAbs) Sales Market Share Forecast by Application (2022-2027) Table 44. Global Recombinant Antibodies (rAbs) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Recombinant Antibodies (rAbs) Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Recombinant Antibodies (rAbs) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/ul) Table 47. United States Recombinant Antibodies (rAbs) Sales (L) of Key Companies (2016-2021) Table 48. United States Recombinant Antibodies (rAbs) Sales Share by Company (2016-2021) Table 49. United States Recombinant Antibodies (rAbs) Revenue (US$ Million) by Company (2016-2021) Table 50. United States Recombinant Antibodies (rAbs) Revenue Share by Company (2016-2021) Table 51. United States Recombinant Antibodies (rAbs) Sales (L) by Type (2016-2021) Table 52. United States Recombinant Antibodies (rAbs) Sales Share by Type (2016-2021) Table 53. United States Recombinant Antibodies (rAbs) Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. United States Recombinant Antibodies (rAbs) Price (US$/ul) by Type (2016-2021) Table 55. United States Recombinant Antibodies (rAbs) Sales (L) by Type (2022-2027) Table 56. United States Recombinant Antibodies (rAbs) Sales Share by Type (2022-2027) Table 57. United States Recombinant Antibodies (rAbs) Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. United States Recombinant Antibodies (rAbs) Revenue Share by Type (2022-2027) Table 59. United States Recombinant Antibodies (rAbs) Price (US$/ul) by Type (2022-2027) Table 60. United States Recombinant Antibodies (rAbs) Sales (L) by Application (2016-2021) Table 61. United States Recombinant Antibodies (rAbs) Sales Share by Application (2016-2021) Table 62. United States Recombinant Antibodies (rAbs) Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. United States Recombinant Antibodies (rAbs) Price (US$/ul) by Application (2016-2021) Table 64. United States Recombinant Antibodies (rAbs) Sales (L) by Application (2022-2027) Table 65. United States Recombinant Antibodies (rAbs) Sales Share by Application (2022-2027) Table 66. United States Recombinant Antibodies (rAbs) Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. United States Recombinant Antibodies (rAbs) Revenue Share by Application (2022-2027) Table 68. United States Recombinant Antibodies (rAbs) Price (US$/ul) by Application (2022-2027) Table 69. North America Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L) Table 70. North America Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021) Table 71. North America Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Recombinant Antibodies (rAbs) Sales by Region (2016-2021) & (L) Table 74. Asia Pacific Recombinant Antibodies (rAbs) Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Recombinant Antibodies (rAbs) Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Recombinant Antibodies (rAbs) Revenue Market Share by Region (2016-2021) Table 77. Europe Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L) Table 78. Europe Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021) Table 79. Europe Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021) Table 81. Latin America Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L) Table 82. Latin America Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Recombinant Antibodies (rAbs) Sales by Country (2016-2021) & (L) Table 86. Middle East and Africa Recombinant Antibodies (rAbs) Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Recombinant Antibodies (rAbs) Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Recombinant Antibodies (rAbs) Revenue Market Share by Country (2016-2021) Table 89. Abcam Corporation Information Table 90. Abcam Description and Business Overview Table 91. Abcam Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 92. Abcam Recombinant Antibodies (rAbs) Product Table 93. Abcam Recent Development Table 94. Abeomics Corporation Information Table 95. Abeomics Description and Business Overview Table 96. Abeomics Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 97. Abeomics Product Table 98. Abeomics Recent Development Table 99. Abnova Corporation Corporation Information Table 100. Abnova Corporation Description and Business Overview Table 101. Abnova Corporation Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 102. Abnova Corporation Product Table 103. Abnova Corporation Recent Development Table 104. Absolute Antibody Corporation Information Table 105. Absolute Antibody Description and Business Overview Table 106. Absolute Antibody Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 107. Absolute Antibody Product Table 108. Absolute Antibody Recent Development Table 109. Activity Signaling Corporation Information Table 110. Activity Signaling Description and Business Overview Table 111. Activity Signaling Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 112. Activity Signaling Product Table 113. Activity Signaling Recent Development Table 114. AIVD Biotech Corporation Information Table 115. AIVD Biotech Description and Business Overview Table 116. AIVD Biotech Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 117. AIVD Biotech Product Table 118. AIVD Biotech Recent Development Table 119. Bio X Cell Corporation Information Table 120. Bio X Cell Description and Business Overview Table 121. Bio X Cell Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 122. Bio X Cell Product Table 123. Bio X Cell Recent Development Table 124. BioLegend Corporation Information Table 125. BioLegend Description and Business Overview Table 126. BioLegend Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 127. BioLegend Product Table 128. BioLegend Recent Development Table 129. Bio-Rad Corporation Information Table 130. Bio-Rad Description and Business Overview Table 131. Bio-Rad Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 132. Bio-Rad Product Table 133. Bio-Rad Recent Development Table 134. Bon Opus Biosciences Corporation Information Table 135. Bon Opus Biosciences Description and Business Overview Table 136. Bon Opus Biosciences Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 137. Bon Opus Biosciences Product Table 138. Bon Opus Biosciences Recent Development Table 139. Creative Biolabs Corporation Information Table 140. Creative Biolabs Description and Business Overview Table 141. Creative Biolabs Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 142. Creative Biolabs Product Table 143. Creative Biolabs Recent Development Table 144. Creative Diagnostics Corporation Information Table 145. Creative Diagnostics Description and Business Overview Table 146. Creative Diagnostics Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 147. Creative Diagnostics Product Table 148. Creative Diagnostics Recent Development Table 149. Enzo Life Sciences, Inc. Corporation Information Table 150. Enzo Life Sciences, Inc. Description and Business Overview Table 151. Enzo Life Sciences, Inc. Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 152. Enzo Life Sciences, Inc. Product Table 153. Enzo Life Sciences, Inc. Recent Development Table 154. GRP GmbH Corporation Information Table 155. GRP GmbH Description and Business Overview Table 156. GRP GmbH Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 157. GRP GmbH Product Table 158. GRP GmbH Recent Development Table 159. HUABIO Corporation Information Table 160. HUABIO Description and Business Overview Table 161. HUABIO Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 162. HUABIO Product Table 163. HUABIO Recent Development Table 164. Miltenyi Biotec Corporation Information Table 165. Miltenyi Biotec Description and Business Overview Table 166. Miltenyi Biotec Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 167. Miltenyi Biotec Product Table 168. Miltenyi Biotec Recent Development Table 169. NSJ Bioreagents Corporation Information Table 170. NSJ Bioreagents Description and Business Overview Table 171. NSJ Bioreagents Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 172. NSJ Bioreagents Product Table 173. NSJ Bioreagents Recent Development Table 174. PROGEN Corporation Information Table 175. PROGEN Description and Business Overview Table 176. PROGEN Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 177. PROGEN Product Table 178. PROGEN Recent Development Table 179. RevMab Biosciences USA, Inc. Corporation Information Table 180. RevMab Biosciences USA, Inc. Description and Business Overview Table 181. RevMab Biosciences USA, Inc. Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 182. RevMab Biosciences USA, Inc. Product Table 183. RevMab Biosciences USA, Inc. Recent Development Table 184. Signalway Antibody LLC Corporation Information Table 185. Signalway Antibody LLC Description and Business Overview Table 186. Signalway Antibody LLC Recombinant Antibodies (rAbs) Sales (L), Revenue (US$ Million), Price (US$/ul) and Gross Margin (2016-2021) Table 187. Signalway Antibody LLC Product Table 188. Signalway Antibody LLC Recent Development Table 189. Recombinant Antibodies (rAbs) Market Trends Table 190. Recombinant Antibodies (rAbs) Market Drivers Table 191. Recombinant Antibodies (rAbs) Market Challenges Table 192. Recombinant Antibodies (rAbs) Market Restraints Table 193. Recombinant Antibodies (rAbs) Customers List Table 194. Recombinant Antibodies (rAbs) Distributors List Table 195. Research Programs/Design for This Report Table 196. Key Data Information from Secondary Sources Table 197. Key Data Information from Primary Sources List of Figures Figure 1. Recombinant Antibodies (rAbs) Product Picture Figure 2. Global Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020 & 2027 Figure 3. Rabbit Product Picture Figure 4. Mouse Product Picture Figure 5. Goat Product Picture Figure 6. Others Product Picture Figure 7. Global Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020 & 2027 Figure 8. Hospitals & Diagnostic Laboratories Figure 9. Pharmaceutical & Biotechnology Figure 10. Research Institutes Figure 11. Others Figure 12. Recombinant Antibodies (rAbs) Report Years Considered Figure 13. Global Recombinant Antibodies (rAbs) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Recombinant Antibodies (rAbs) Market Size 2016-2027 (US$ Million) Figure 15. Global Recombinant Antibodies (rAbs) Sales 2016-2027 (L) Figure 16. Global Recombinant Antibodies (rAbs) Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Recombinant Antibodies (rAbs) Sales Market Share by Region (2016-2021) Figure 18. Global Recombinant Antibodies (rAbs) Sales Market Share by Region in 2020 Figure 19. Global Recombinant Antibodies (rAbs) Revenue Market Share by Region (2016-2021) Figure 20. Global Recombinant Antibodies (rAbs) Revenue Market Share by Region in 2020 Figure 21. Global Recombinant Antibodies (rAbs) Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by Recombinant Antibodies (rAbs) Revenue in 2020 Figure 23. Recombinant Antibodies (rAbs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Recombinant Antibodies (rAbs) Sales Market Share by Type (2016-2021) Figure 25. Global Recombinant Antibodies (rAbs) Sales Market Share by Type in 2020 Figure 26. Global Recombinant Antibodies (rAbs) Revenue Market Share by Type (2016-2021) Figure 27. Global Recombinant Antibodies (rAbs) Revenue Market Share by Type in 2020 Figure 28. Global Recombinant Antibodies (rAbs) Sales Market Share by Application (2016-2021) Figure 29. Global Recombinant Antibodies (rAbs) Sales Market Share by Application in 2020 Figure 30. Global Recombinant Antibodies (rAbs) Revenue Market Share by Application (2016-2021) Figure 31. Global Recombinant Antibodies (rAbs) Revenue Market Share by Application in 2020 Figure 32. United States Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2027 (L) Figure 33. United States Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. United States Recombinant Antibodies (rAbs) Market Share in Global Market 2016-2027 Figure 35. United States 5 and 10 Largest Recombinant Antibodies (rAbs) Players Market Share by Revenue in Recombinant Antibodies (rAbs) in 2020 Figure 36. United States Recombinant Antibodies (rAbs) Revenue Share by Type (2016-2021) Figure 37. United States Recombinant Antibodies (rAbs) Revenue Growth Rate by Type in 2016 & 2020 Figure 38. United States Recombinant Antibodies (rAbs) Revenue Share by Application (2016-2021) Figure 39. United States Recombinant Antibodies (rAbs) Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2021 (L) Figure 41. North America Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020 Figure 43. North America Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020 Figure 44. United States Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 45. United States Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 47. Canada Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2021 (L) Figure 49. Europe Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020 Figure 51. Europe Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020 Figure 52. Germany Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 53. Germany Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 55. France Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 57. U.K. Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 59. Italy Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 61. Russia Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2021 (L) Figure 63. Asia Pacific Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific Recombinant Antibodies (rAbs) Sales Market Share by Region in 2020 Figure 65. Asia Pacific Recombinant Antibodies (rAbs) Revenue Market Share by Region in 2020 Figure 66. China Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 67. China Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 69. Japan Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 71. South Korea Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 73. India Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 75. Australia Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. China Taiwan Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 77. China Taiwan Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 79. Indonesia Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Thailand Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 81. Thailand Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Malaysia Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 83. Malaysia Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2021 (L) Figure 85. Latin America Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020 Figure 87. Latin America Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020 Figure 88. Mexico Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 89. Mexico Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 91. Brazil Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 93. Argentina Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Recombinant Antibodies (rAbs) Sales Growth Rate 2016-2021 (L) Figure 95. Middle East and Africa Recombinant Antibodies (rAbs) Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Recombinant Antibodies (rAbs) Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Recombinant Antibodies (rAbs) Revenue Market Share by Country in 2020 Figure 98. Turkey Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 99. Turkey Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 101. Saudi Arabia Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Recombinant Antibodies (rAbs) Sales Growth Rate (2016-2021) (L) Figure 103. UAE Recombinant Antibodies (rAbs) Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Recombinant Antibodies (rAbs) Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

Abcam Abeomics Abnova Corporation Absolute Antibody Activity Signaling AIVD Biotech Bio X Cell BioLegend Bio-Rad Bon Opus Biosciences Creative Biolabs Creative Diagnostics Enzo Life Sciences, Inc. GRP GmbH HUABIO Miltenyi Biotec NSJ Bioreagents PROGEN RevMab Biosciences USA, Inc. Signalway Antibody LLC